Use of Digital Technology to Enhance Tuberculosis Control: Scoping Review.
eHealth
mHealth
medical informatics
tuberculosis
Journal
Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882
Informations de publication
Date de publication:
13 02 2020
13 02 2020
Historique:
received:
19
09
2019
accepted:
22
10
2019
revised:
22
10
2019
entrez:
14
2
2020
pubmed:
14
2
2020
medline:
21
10
2020
Statut:
epublish
Résumé
Tuberculosis (TB) is the leading cause of death from a single infectious agent, with around 1.5 million deaths reported in 2018, and is a major contributor to suffering worldwide, with an estimated 10 million new cases every year. In the context of the World Health Organization's End TB strategy and the quest for digital innovations, there is a need to understand what is happening around the world regarding research into the use of digital technology for better TB care and control. The purpose of this scoping review was to summarize the state of research on the use of digital technology to enhance TB care and control. This study provides an overview of publications covering this subject and answers 3 main questions: (1) to what extent has the issue been addressed in the scientific literature between January 2016 and March 2019, (2) which countries have been investing in research in this field, and (3) what digital technologies were used? A Web-based search was conducted on PubMed and Web of Science. Studies that describe the use of digital technology with specific reference to keywords such as TB, digital health, eHealth, and mHealth were included. Data from selected studies were synthesized into 4 functions using narrative and graphical methods. Such digital health interventions were categorized based on 2 classifications, one by function and the other by targeted user. A total of 145 relevant studies were identified out of the 1005 published between January 2016 and March 2019. Overall, 72.4% (105/145) of the research focused on patient care and 20.7% (30/145) on surveillance and monitoring. Other programmatic functions 4.8% (7/145) and electronic learning 2.1% (3/145) were less frequently studied. Most digital health technologies used for patient care included primarily diagnostic 59.4% (63/106) and treatment adherence tools 40.6% (43/106). On the basis of the second type of classification, 107 studies targeted health care providers (107/145, 73.8%), 20 studies targeted clients (20/145, 13.8%), 17 dealt with data services (17/145, 11.7%), and 1 study was on the health system or resource management. The first authors' affiliations were mainly from 3 countries: the United States (30/145 studies, 20.7%), China (20/145 studies, 13.8%), and India (17/145 studies, 11.7%). The researchers from the United States conducted their research both domestically and abroad, whereas researchers from China and India conducted all studies domestically. The majority of research conducted between January 2016 and March 2019 on digital interventions for TB focused on diagnostic tools and treatment adherence technologies, such as video-observed therapy and SMS. Only a few studies addressed interventions for data services and health system or resource management.
Sections du résumé
BACKGROUND
Tuberculosis (TB) is the leading cause of death from a single infectious agent, with around 1.5 million deaths reported in 2018, and is a major contributor to suffering worldwide, with an estimated 10 million new cases every year. In the context of the World Health Organization's End TB strategy and the quest for digital innovations, there is a need to understand what is happening around the world regarding research into the use of digital technology for better TB care and control.
OBJECTIVE
The purpose of this scoping review was to summarize the state of research on the use of digital technology to enhance TB care and control. This study provides an overview of publications covering this subject and answers 3 main questions: (1) to what extent has the issue been addressed in the scientific literature between January 2016 and March 2019, (2) which countries have been investing in research in this field, and (3) what digital technologies were used?
METHODS
A Web-based search was conducted on PubMed and Web of Science. Studies that describe the use of digital technology with specific reference to keywords such as TB, digital health, eHealth, and mHealth were included. Data from selected studies were synthesized into 4 functions using narrative and graphical methods. Such digital health interventions were categorized based on 2 classifications, one by function and the other by targeted user.
RESULTS
A total of 145 relevant studies were identified out of the 1005 published between January 2016 and March 2019. Overall, 72.4% (105/145) of the research focused on patient care and 20.7% (30/145) on surveillance and monitoring. Other programmatic functions 4.8% (7/145) and electronic learning 2.1% (3/145) were less frequently studied. Most digital health technologies used for patient care included primarily diagnostic 59.4% (63/106) and treatment adherence tools 40.6% (43/106). On the basis of the second type of classification, 107 studies targeted health care providers (107/145, 73.8%), 20 studies targeted clients (20/145, 13.8%), 17 dealt with data services (17/145, 11.7%), and 1 study was on the health system or resource management. The first authors' affiliations were mainly from 3 countries: the United States (30/145 studies, 20.7%), China (20/145 studies, 13.8%), and India (17/145 studies, 11.7%). The researchers from the United States conducted their research both domestically and abroad, whereas researchers from China and India conducted all studies domestically.
CONCLUSIONS
The majority of research conducted between January 2016 and March 2019 on digital interventions for TB focused on diagnostic tools and treatment adherence technologies, such as video-observed therapy and SMS. Only a few studies addressed interventions for data services and health system or resource management.
Identifiants
pubmed: 32053111
pii: v22i2e15727
doi: 10.2196/15727
pmc: PMC7055857
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15727Informations de copyright
©Yejin Lee, Mario C Raviglione, Antoine Flahault. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 13.02.2020.
Références
BMC Public Health. 2019 Jan 22;19(1):99
pubmed: 30669990
Medicine (Baltimore). 2016 May;95(18):e3511
pubmed: 27149451
Front Cell Infect Microbiol. 2017 Aug 11;7:369
pubmed: 28848722
BMJ Glob Health. 2016 Aug 12;1(2):e000038
pubmed: 28588935
J Clin Microbiol. 2017 Nov;55(11):3267-3282
pubmed: 28904183
Indian J Pediatr. 2019 May;86(5):441-447
pubmed: 30628039
PLoS One. 2018 Jul 3;13(7):e0199687
pubmed: 29969486
JMIR Mhealth Uhealth. 2018 Nov 20;6(11):e10239
pubmed: 30459147
Euro Surveill. 2018 Nov;23(44):
pubmed: 30401009
J Health Commun. 2016 Oct;21(10):1115-21
pubmed: 27668973
J Thorac Dis. 2018 Mar;10(3):1936-1940
pubmed: 29707349
MMWR Recomm Rep. 1995 Sep 8;44(RR-11):1-16
pubmed: 7565539
J Microbiol Methods. 2016 Oct;129:39-43
pubmed: 27425377
Iran J Microbiol. 2017 Feb;9(1):38-42
pubmed: 28775822
Patient Prefer Adherence. 2017 Aug 31;11:1479-1487
pubmed: 28919720
Lung India. 2019 Mar-Apr;36(2):108-111
pubmed: 30829243
Int J Infect Dis. 2017 Jun;59:96-102
pubmed: 28457751
Eur Respir J. 2018 Feb 7;51(2):
pubmed: 29437940
J Am Med Inform Assoc. 2017 Apr 1;24(e1):e136-e142
pubmed: 27589943
ERJ Open Res. 2018 Feb 02;4(1):
pubmed: 29410957
Stud Health Technol Inform. 2017;237:204-208
pubmed: 28479569
Anal Biochem. 2018 Mar 1;544:98-107
pubmed: 29305096
Int J Tuberc Lung Dis. 2018 Mar 1;22(3):328-335
pubmed: 29471912
PLoS One. 2019 Feb 27;14(2):e0212094
pubmed: 30811445
PLoS One. 2017 Apr 18;12(4):e0176051
pubmed: 28419149
J Infect. 2017 Nov;75(5):441-447
pubmed: 28804027
BMC Public Health. 2019 Mar 18;19(1):321
pubmed: 30885160
Stud Health Technol Inform. 2018;250:32
pubmed: 29857363
Lancet Infect Dis. 2017 Apr;17(4):441-450
pubmed: 28063795
Int J Tuberc Lung Dis. 2018 May 1;22(5):476
pubmed: 29663949
Eur Respir J. 2018 Nov 1;52(5):
pubmed: 30166325
EBioMedicine. 2019 Feb;40:564-573
pubmed: 30745169
Mhealth. 2017 Jul 27;3:30
pubmed: 28828377
AIDS Behav. 2016 May;20(5):1097-107
pubmed: 26604004
Mem Inst Oswaldo Cruz. 2016 Sep;111(9):545-50
pubmed: 27598243
Zhongguo Gu Shang. 2017 Sep 25;30(9):787-791
pubmed: 29455477
J Med Syst. 2018 May 8;42(6):113
pubmed: 29737418
Int J Tuberc Lung Dis. 2010 Oct;14(10):1215-21
pubmed: 20843410
BMC Public Health. 2016 Jul 13;16:563
pubmed: 27412114
BMC Infect Dis. 2017 Apr 24;17(1):301
pubmed: 28438139
PeerJ. 2017 Jul 14;5:e3567
pubmed: 28717600
PLoS One. 2019 Jan 25;14(1):e0209320
pubmed: 30682028
ERJ Open Res. 2017 Jun 21;3(2):
pubmed: 28656130
Zhonghua Er Ke Za Zhi. 2016 May;54(5):370-4
pubmed: 27143080
Eur Respir J. 2017 Mar 22;49(3):
pubmed: 28331042
J Acquir Immune Defic Syndr. 2017 Jan 01;74 Suppl 1:S37-S43
pubmed: 27930610
ACS Sens. 2018 Oct 26;3(10):2079-2086
pubmed: 30269480
Comput Biol Med. 2018 Jul 1;98:76-84
pubmed: 29775913
J Med Internet Res. 2018 Nov 20;20(11):e287
pubmed: 30459146
Glob Health Action. 2016 Jun 23;9:30528
pubmed: 27341793
Tuberculosis (Edinb). 2018 Jan;108:1-9
pubmed: 29523307
Lancet. 2019 Mar 23;393(10177):1216-1224
pubmed: 30799062
Lancet. 2019 Mar 23;393(10177):1180-1181
pubmed: 30799059
Epidemiol Infect. 2018 Oct;146(14):1756-1762
pubmed: 29976264
Int J Infect Dis. 2017 Dec;65:85-89
pubmed: 29030137
Microbiol Spectr. 2017 Jan;5(1):
pubmed: 28155817
Sci Rep. 2018 Feb 14;8(1):3003
pubmed: 29445235
Int J Tuberc Lung Dis. 2016 Aug;20(8):999-1003
pubmed: 27393530
Tuberculosis (Edinb). 2016 Jul;99:47-53
pubmed: 27450004
Am J Respir Crit Care Med. 2019 Aug 1;200(3):370-380
pubmed: 30694692
ERJ Open Res. 2019 Feb 01;5(1):
pubmed: 30723725
Clin Imaging. 2016 May-Jun;40(3):461-4
pubmed: 27133687
J Med Syst. 2017 Nov 27;42(1):12
pubmed: 29181590
Indian J Tuberc. 2019 Jan;66(1):193-196
pubmed: 30878068
MMWR Morb Mortal Wkly Rep. 2017 Apr 14;66(14):387-389
pubmed: 28406884
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016 Jan;45(1):61-7
pubmed: 27045243
Biomed Res Int. 2017;2017:1058579
pubmed: 28168192
Clin Infect Dis. 2018 Nov 28;67(suppl_3):S293-S302
pubmed: 30496461
J Public Health Manag Pract. 2017 Mar/Apr;23(2):175-177
pubmed: 27598709
Public Health Action. 2018 Mar 21;8(1):29
pubmed: 29581942
Emerg Infect Dis. 2018 Oct;24(10):1806-1815
pubmed: 30226154
IEEE Trans Med Imaging. 2016 Apr;35(4):1013-24
pubmed: 26660889
Int J Infect Dis. 2017 Mar;56:229-236
pubmed: 27836795
PLoS One. 2017 Feb 2;12(2):e0171310
pubmed: 28152082
Sci Rep. 2018 Aug 17;8(1):12339
pubmed: 30120345
Diagn Microbiol Infect Dis. 2017 Dec;89(4):276-281
pubmed: 28974394
J Public Health Manag Pract. 2018 Nov/Dec;24(6):567-570
pubmed: 28692611
BMC Infect Dis. 2018 Apr 11;18(1):171
pubmed: 29642874
Ann Clin Microbiol Antimicrob. 2019 Jan 3;18(1):2
pubmed: 30606210
JMIR Mhealth Uhealth. 2019 Feb 01;7(2):e11638
pubmed: 30707103
Open Forum Infect Dis. 2018 Apr 26;5(4):ofy046
pubmed: 29732378
Asia Pac J Public Health. 2018 Sep;30(6):542-550
pubmed: 30261738
Eur Respir J. 2017 Nov 9;50(5):
pubmed: 29122920
ERJ Open Res. 2017 May 12;3(2):
pubmed: 28512634
Trop Med Int Health. 2018 Aug;23(8):850-859
pubmed: 29862612
J Med Internet Res. 2018 Nov 15;20(11):e11541
pubmed: 30442637
JMIR Med Inform. 2018 Feb 27;6(1):e12
pubmed: 29487047
Sci Rep. 2016 Apr 29;6:25265
pubmed: 27126741
Int J Tuberc Lung Dis. 2019 Feb 1;23(2):219-225
pubmed: 30808455
Int J Med Inform. 2017 Jun;102:118-129
pubmed: 28495339
Iran J Public Health. 2018 Jan;47(1):18-23
pubmed: 29318113
Eur Radiol. 2016 Sep;26(9):2999-3005
pubmed: 26747256
JMIR Mhealth Uhealth. 2016 May 13;4(2):e25
pubmed: 27177591
Rev Lat Am Enfermagem. 2017 Dec 11;25:e2964
pubmed: 29236840
BMC Health Serv Res. 2017 Aug 22;17(1):575
pubmed: 28830542
Infez Med. 2016 Dec 1;24(4):304-309
pubmed: 28011966
Eur Respir J. 2018 Jan 11;51(1):
pubmed: 29326332
Int J Environ Res Public Health. 2019 Jan 16;16(2):
pubmed: 30654560
Afr J Lab Med. 2017 Mar 31;6(2):420
pubmed: 28879158
Glob Health Sci Pract. 2016 Jun 27;4(2):211-21
pubmed: 27353615
PLoS One. 2018 May 10;13(5):e0197022
pubmed: 29746507
BMC Res Notes. 2017 Feb 14;10(1):96
pubmed: 28193251
J Immigr Minor Health. 2018 Jun;20(3):687-696
pubmed: 28584959
JMIR Mhealth Uhealth. 2019 Feb 19;7(2):e12385
pubmed: 30777847
Syst Rev. 2017 Oct 25;6(1):215
pubmed: 29070061
Indian J Med Microbiol. 2017 Jul-Sep;35(3):323-331
pubmed: 29063875
MMWR Morb Mortal Wkly Rep. 2017 Dec 22;66(50):1386-1387
pubmed: 29267264
Eur Respir J. 2017 Jul 13;50(1):
pubmed: 28705949
Zhonghua Jie He He Hu Xi Za Zhi. 2017 Dec 12;40(12):946-947
pubmed: 29224308
Front Microbiol. 2019 Mar 04;10:395
pubmed: 30886608
Emerg Infect Dis. 2016 Mar;22(3):538-40
pubmed: 26891363
Int J Tuberc Lung Dis. 2016 May;20(5):588-93
pubmed: 27084810
BMC Res Notes. 2016 Mar 05;9:146
pubmed: 26945749
BMC Infect Dis. 2016 Aug 03;16:366
pubmed: 27487852
Public Health Action. 2017 Jun 21;7(2):123-126
pubmed: 28695085
JMIR Mhealth Uhealth. 2019 Apr 03;7(4):e11687
pubmed: 30942696
Zhonghua Liu Xing Bing Xue Za Zhi. 2016 May;37(5):668-72
pubmed: 27188359
Int J Tuberc Lung Dis. 2016 Sep;20(9):1226-30
pubmed: 27510250
J Infect. 2016 May;72(5):573-86
pubmed: 26850356
BMC Infect Dis. 2019 Feb 4;19(1):110
pubmed: 30717693
Glob Health Action. 2017;10(1):1360560
pubmed: 28849725
Stud Health Technol Inform. 2016;225:936-7
pubmed: 27332418
Eur Respir J. 2016 Jul;48(1):29-45
pubmed: 27230443
Int J Tuberc Lung Dis. 2018 Sep 1;22(9):1088-1094
pubmed: 30092877
Indian J Tuberc. 2018 Jul;65(3):185-186
pubmed: 29933857
PLoS One. 2017 Mar 2;12(3):e0173092
pubmed: 28253302
Pediatr Radiol. 2016 Sep;46(10):1384-91
pubmed: 27173982
Braz J Infect Dis. 2016 May-Jun;20(3):235-41
pubmed: 27020707
Nursing. 2018 May;48(5):64-66
pubmed: 29697568
Pilot Feasibility Stud. 2017 Mar 13;3:15
pubmed: 28293431
Clin Microbiol Infect. 2019 Jan;25(1):82-86
pubmed: 29653190